Literature DB >> 21181393

[Sudden unilateral loss of vision under high-dosage corticosteroid therapy for pansinusitis].

F Alten1, C H Meyer.   

Abstract

Endogenous and exogenous glucocorticoids are suspected to play a key role in the development of central serous chorioretinopathy (CSC), which is characterized by a serous detachment of the neurosensory retina caused by the accumulation of fluid between the retinal pigment epithelium and the photoreceptor layer. We report the case of a patient with pansinusitis who was treated with high-dose corticosteroids and developed CSC. Patients under systemic corticosteroid therapy should be informed about the associated risk and symptoms of CSC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21181393     DOI: 10.1007/s00106-010-2221-8

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  8 in total

Review 1.  Central serous chorioretinopathy and glucocorticoids.

Authors:  Evrydiki A Bouzas; Panagiotis Karadimas; Constantin J Pournaras
Journal:  Surv Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 6.048

2.  Alexithymia and emotional distress in patients with central serous chorioretinopathy.

Authors:  Rupert Conrad; Nina Friederike Weber; Matthias Lehnert; Frank Gerhard Holz; Reinhard Liedtke; Nicole Eter
Journal:  Psychosomatics       Date:  2007 Nov-Dec       Impact factor: 2.386

3.  Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.

Authors:  Ozgur Artunay; Erdal Yuzbasioglu; Rifat Rasier; Alper Sengul; Halil Bahcecioglu
Journal:  Curr Eye Res       Date:  2010-02       Impact factor: 2.424

4.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

5.  Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up.

Authors:  E Burumcek; A Mudun; S Karacorlu; M O Arslan
Journal:  Ophthalmology       Date:  1997-04       Impact factor: 12.079

6.  [Central serous chorioretinopathy (CSC) and corticosteroids].

Authors:  B M Stoffelns; C Kramann; K Schoepfer
Journal:  Klin Monbl Augenheilkd       Date:  2008-05       Impact factor: 0.700

7.  Acetazolamide for central serous retinopathy.

Authors:  Joseph Pikkel; Itzchak Beiran; Avinoam Ophir; Benjamin Miller
Journal:  Ophthalmology       Date:  2002-09       Impact factor: 12.079

8.  Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy.

Authors:  Makoto Koyama; Atsushi Mizota; Yoshinori Igarashi; Emiko Adachi-Usami
Journal:  Ophthalmologica       Date:  2004 Mar-Apr       Impact factor: 3.250

  8 in total
  1 in total

1.  Unilateral, recurrent exudative retinal detachment in association with pansinusitis.

Authors:  Ali Osman Saatci; Zeynep Ozbek Soylemezoglu; Ozlem Barut Selver; M Cenk Ecevit; Emel Ada
Journal:  GMS Ophthalmol Cases       Date:  2012-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.